Centella AsiaticavsTretinoin

The four key triterpenoid saponins—madecassoside, asiaticoside, madecassic acid, and asiatic acid—exert distinct but complementary mechanisms. Madecassoside and asiaticoside are anti-inflammatory: they inhibit NF-κB nuclear translocation and IκB kinase activity, reducing TNF-α, IL-6, and IL-1β production in keratinocytes and dermal cells. Madecassic acid and asiatic acid (the aglycone forms) stimulate type I and III collagen synthesis in fibroblasts by upregulating collagen gene expression and procollagen production. All four compounds promote wound healing by stimulating angiogenesis via VEGF (vascular endothelial growth factor) upregulation, fibroblast proliferation and migration, and extracellular matrix remodeling. Centella extracts also increase superoxide dismutase (SOD) and catalase activity in skin cells, enhancing endogenous antioxidant defense. The triterpenes may modulate TGF-β and Smad signaling. TECA (Titrated Extract of Centella Asiatica) standardizes these actives for consistent clinical efficacy.

Tretinoin binds nuclear retinoic acid receptors (RAR-alpha, beta, gamma), forming RAR/RXR heterodimers that bind retinoic acid response elements and activate gene transcription. This accelerates keratinocyte proliferation, reducing stratum corneum transit from ~28 to ~14 days. In the dermis, tretinoin stimulates fibroblasts and upregulates collagen I and III via TGF-beta while downregulating MMP-1, MMP-3, and MMP-9 that degrade the extracellular matrix. It normalizes melanocyte distribution and melanosome transfer. In acne, it prevents microcomedo formation by normalizing follicular keratinocyte differentiation and reducing corneocyte cohesion. RAR activation also modulates genes for epidermal growth factors and differentiation markers.